Navigation Links
MADIT-CRT Trial Data Show Women Received Greater Benefit From CRT-Ds Than Men
Date:6/18/2010

sclaim any intention or obligation to publicly update or revise any forward-looking statements to reflect any change in our expectations or in events, conditions, or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements. This cautionary statement is applicable to all forward-looking statements contained in this document.

---------------------------------

[1] The NYHA clinical classifications of heart failure rank patients as Class I-II-III-IV, according to the degree of symptoms or functional limits, from asymptomatic to bed ridden. MADIT-CRT patients are asymptomatic or mildly symptomatic, NYHA Class I (ischemic) and Class II (ischemic and non-ischemic).

[2] High-risk is defined as QRS width >130 milliseconds with Left Ventricular Ejection Fraction < 30 percent and Left Bundle Branch Block (LBBB). LBBB is a condition in which the activation of the left ventricle is delayed. As a result, portions of the left ventricle contract later than the rest of the left ventricle and right ventricle, reducing the heart's pumping ability.

    Contact:

    Paul Donovan
    +1-508-650-8541 (office)
    +1-508-667-5165 (mobile)
    Media Relations
    Boston Scientific Corporation

    David Knutson
    +1-651-582-6574 (office)
    +1-651-260-8288 (mobile)
    Media Relations
    Boston Scientific Corporation

    Larry Neumann
    +1-508-650-8696 (office)
    Investor Relations
    Boston Scientific Corporation


'/>"/>
SOURCE Boston Scientific Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Boston Scientific to Webcast Conference Call Discussing Results of Landmark MADIT-CRT Trial
2. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
3. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
6. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
7. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
8. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
9. Phase III Trial Finds Pharmaxis Bronchitol Effective
10. YM BioSciences USA cleared by US FDA to initiate Phase II clinical trial of nimotuzumab in children with inoperable, recurrent brain cancer
11. YM BIOSCIENCES ANNOUNCES POSITIVE PRELIMINARY RESULTS FROM PHASE I/II LUNG CANCER TRIAL OF NIMOTUZUMAB COMBINED WITH RADIATION
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... 2014 Appistry, Inc. , a ... the power of genomics to next-generation medicine, announced today ... Challenge . , Two Appistry staff will be ... Center for Genome Resources, and Mr. Neil Miller, director ... Kansas City. Rounding out the panel are Appistry’s Dr. ...
(Date:7/28/2014)... 28, 2014 It’s a hard truth: Nearly ... to further their post-secondary education are failing to obtain a ... this year. And according to an analysis by The ... veteran students’ uninformed choice of college majors, which leads to ... the study: Some 51.7 percent of post-9/11 veterans using ...
(Date:7/28/2014)... July 28, 2014 The global market ... by 2020, according to a new study by Grand ... rising demand for effective vaccines and drugs in an ... medical needs is expected to drive market demand over ... enhance agricultural productivity via the use of genetically engineered ...
(Date:7/28/2014)... 2014  InterMune, Inc. (NASDAQ: ITMN ) ... 2014 financial results at the close of the U.S. ... and webcast will be hosted by InterMune at 4:30 ... investors and others may participate in the conference call ... ID#21728775. A replay of the webcast and teleconference will be ...
Breaking Biology Technology:Appistry Names Industry Experts from the National Center for Genome Resources and Mercy Children's, Kansas City, to Judge Pipeline Challenge Competition 2Resume Place: To Choose the Best College Majors, Veterans Need Early Career Counseling, Data Shows 2Resume Place: To Choose the Best College Majors, Veterans Need Early Career Counseling, Data Shows 3Resume Place: To Choose the Best College Majors, Veterans Need Early Career Counseling, Data Shows 4Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 2Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 3Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 4InterMune to Release Second Quarter Financial Results on August 6 2
... , , , , , ... in eukaryotic cell cultures , requires double-stranded molecules known ... licensed supplier of siRNA, offering a custom , ... directed against common target genes, and a Cancer , ...
... For transfection of eukaryotic cells with RNA and siRNA , , , , , , ... Kit Contents , Storage and Stability ... Technical Assistance , Product Use Limitations ... Safety Information , ...
... QIAshredder spin columns are designed for simple and rapid homogenization , of cell and tissue lysates. ... , , Format: , ... , , Sample source: , ... plant cell or tissue lysates, white blood cell lysates, , ...
Cached Biology Technology:RNAi Gene Silencing System 2RNAi Gene Silencing System 3TransMessenger Transfection Reagent Handbook 2TransMessenger Transfection Reagent Handbook 3TransMessenger Transfection Reagent Handbook 4TransMessenger Transfection Reagent Handbook 5TransMessenger Transfection Reagent Handbook 6TransMessenger Transfection Reagent Handbook 7TransMessenger Transfection Reagent Handbook 8TransMessenger Transfection Reagent Handbook 9TransMessenger Transfection Reagent Handbook 10TransMessenger Transfection Reagent Handbook 11TransMessenger Transfection Reagent Handbook 12TransMessenger Transfection Reagent Handbook 13TransMessenger Transfection Reagent Handbook 14TransMessenger Transfection Reagent Handbook 15TransMessenger Transfection Reagent Handbook 16TransMessenger Transfection Reagent Handbook 17TransMessenger Transfection Reagent Handbook 18TransMessenger Transfection Reagent Handbook 19TransMessenger Transfection Reagent Handbook 20TransMessenger Transfection Reagent Handbook 21TransMessenger Transfection Reagent Handbook 22TransMessenger Transfection Reagent Handbook 23TransMessenger Transfection Reagent Handbook 24TransMessenger Transfection Reagent Handbook 25QIAshredder Homogenizer 2
(Date:7/28/2014)... Roald Amundsen became the first man to reach the ... years later, an international team of scientists led by ... proven that air pollution from industrial activities arrived long ... from widely spaced locations around the Antarctic continent, including ... and precise reconstruction to date of lead pollution over ...
(Date:7/27/2014)... in vitro study has revealed that nicotine and cotinine, ... caused by a certain carcinogen in smoke. , The ... of tobacco leaves and ultimately ends up in the ... lung and liver, where it is activated by a ... in mice has revealed that nicotine can partially interfere ...
(Date:7/27/2014)... that wiped them out if it had taken place ... A fresh study using up-to-date fossil records and improved ... narrative of the prehistoric creatures, demise, some 66 million ... million years before a 10km-wide asteroid struck what is ... extensive volcanic activity, changing sea levels and varying temperatures. ...
Breaking Biology News(10 mins):Industrial lead pollution beat explorers to the South Pole by 22 years and persists today 2Industrial lead pollution beat explorers to the South Pole by 22 years and persists today 3Nicotine found to inhibit DNA-strand break caused by a certain carcinogen in smoke 2Dinosaurs fell victim to perfect storm of events, study shows 2
... to make proteins, key building blocks of all organisms, ... instructions for assembling them. An Iowa State ... marking where these instructions are located in a cell,s ... Journal of Biological Chemistry , Michael Shogren-Knaak, assistant professor ...
... Service scientists have completed a study on a beetle that ... attacked 67 percent of the oak trees in an area ... in the current issue of The Pan-Pacific Entomologist ... so rare it does not even have an accepted common ...
... of Eve to the venomous murder of the mighty Thor, ... of mischief and misery. The worldwide prominence of ... to the serpentbut why, when so few of us have ... Davis, anthropology professor Lynne A. Isbell suggests, lies in the ...
Cached Biology News:New Southern California beetle killing oaks 2
Viral CMV UL146/vCXC1 Biotinylated Affinity Purified PAb...
Cyan Standard is 7-hydroxy-4-trifluoromethylcoumarin...
... small volume applications, including pediatric, neonatal, geriatric, general adult, veterinary and experimental animals. Automatic Calibration with ... ... ... ...
X-Gal, 100 mg. 5-Bromo-4-chloro-3-indolyl-b-d-galactoside.Histochemical substrate for b-galactosidase, used in blue/white screening.Store at -20 C. Protect from moisture. Category: Nucleotides & Enzy...
Biology Products: